Coming from different specialty with very high base ranges. Wanted to know if there’s negotiation room for starting base? I’ve heard it’s less than 100k?! I realize ICP may be large, but that base seems crazy low. Thanks
Allergan plc reported a 3% improvement in revenues to $3.7 billion for the first quarter of 2018 compared to the prior year period, driven by a 13% increase in its core business which includes the Botox and Juvederm brands.
Net loss for the quarter was $332.5 million or $0.99 per diluted share...
Revance Therapeutics reports positive data for RT002. http://alph.st/b96326ac
A threat to Allergan's Botox, which accounted for 19% of total revenue in Allergan's recently ended quarter.